To evaluate the use of a human fibrin tissue adhesive in the adherence of corneal lamellar flaps in rabbit eyes.
T he fibrinogen-thrombin adhesive system, which has been used in ophthalmology since the early 1980s, was first used to fill injuries of the lens. 1 It was not until the 1990s that a more general study of potential ophthalmic applications of this adhesive was undertaken, 2 in part because the adhesive became available commercially, but more im-portantly, because at that time, the fibrin was combined with aprotinin to retard dissolution of the adhesive bond.
Some of the uses evaluated included closure of the conjunctiva 3 as well as reattachment of the extraocular muscles 4 in strabismus surgery, conjunctival closure in glaucoma surgery, 5 closure of the scleral tunnel after cataract surgery, 6 and enhancement of healing and stabilization of radial keratotomy wounds. 7, 8 Fibrin glue has also been used with amniotic membrane grafts to seal corneal perforations. 9 To our knowledge, however, our study is the first trial of a commercially available fibrin-aprotinin tissue adhesive for corneal lamellar reattachment.
When the epithelium is disrupted during lamellar keratectomy performed with a microkeratome, adhesion of the corneal flap is dramatically reduced and is not reestablished until the surface of the flap is reepithelialized by the fluid-impermeable epithelium, just as laser-assisted in situ keratomileusis (LASIK) flaps with large epithelial defects adhere less well and have more epithelial ingrowth. [10] [11] [12] If a tissue adhesive could be used safely to enhance reattachment of the flap, it might not only permit more reliable flap adhesion but also could shorten the procedure time and might reduce astigmatism compared with corneal suturing. The purpose of this study was to determine whether a fibrin adhesive can help microkeratome flaps adhere to the stroma underneath, with the goal of permitting sutureless lamellar keratoplasty. 
METHODS

Tissue Adhesive
The tissue adhesive (Tisseel VH Fibrin Sealant; Baxter Healthcare Corp., Glendale, CA), which is an FDA-approved, commercially available product that is provided in kit form, was prepared for use according to the manufacturer's instructions. Briefly, the freeze-dried sealer protein concentrate was reconstituted with the fibrinolysis inhibitor solution, and the freeze-dried thrombin solution was reconstituted with a calcium chloride solution. Then equal amounts of the two components were transferred to the sterile surgical field and loaded into a doublechambered syringe.
Surgical Procedure
All animals involved in this study were treated in accordance with the ARVO Resolution on the Use of Animals in Ophthalmic and Vision Research. Six New Zealand white rabbits weighing 3 to 6 lb each were used. The animals were anesthetized with 2 mL ketamine injected intramuscularly (100 mg/mL; Schering-Plough, Kenilworth, NJ). The corneal epithelium was mechanically scraped from both eyes. A microkeratome (Automatic Corneal Shaper, Bausch & Lomb, San Dimas, CA) was used to create a nasally hinged corneal flap approximately 160 µm thick in each eye. All flaps were irrigated, and any debris present in the interface was washed away with saline solution (BSS, Alcon Surgical, Fort Worth, TX). In the right eyes, the flaps were reposited with tissue adhesive. The flap was held down with a Paton spatula, and the adhesive was instilled under the flap through a cannula from a double syringe that mixed the components. In the left eyes, the flaps were reposited without tissue adhesive. Topical antibiotics (Ocuflox, Allergan, Irvine, CA) and topical steroids (Pred Forte, Allergan) were applied to each eye once a day for 3 days after surgery.
Slit-Lamp Biomicroscopy and Histology
Slit-lamp examination and photography were carried out on days 1 and 10 after surgery. Rabbits with surviving flaps were killed on day 10, and the corneas were processed for histopathologic examination. Corneas were processed on a masked basis. Tissues were fixed in a solution of paraformaldehyde and glutaraldehyde (2%), placed in 2% osmium solution, dehydrated in increasing concentrations of alcohol to 100%, infiltrated in plastic (Embed 812, Electron Microscopy Sciences, Fort Washington, PA), polymerized at 60°C for 48 hours, and sectioned on a microtome (MT-700; Sorval).
RESULTS
Of the six flaps glued to the cornea with the tissue adhesive, one was dislocated and five remained in place until the end of the study (day 10 after surgery). On day 10, the five eyes with the surviving flaps had clear corneas on slit-lamp examination. Histopathologic examination of these eyes at 10 days showed no gapping or debris in the interface ( Fig. 1 ). Only minimal reactive fibroblastic transformation of some keratocytes at the interface was seen; this was considered part of the normal healing process (Table 1 ).
In the control eyes, with no adhesive, three of the six flaps were dislocated. The three eyes with surviving flaps at 10 days were clear. On histopathologic examination, one of the three corneas showed microscopic gapping, and all three showed tissue debris at the interface ( Table 2 and Fig. 2 ).
DISCUSSION
The results of this study showed that the tissue adhesive was biocompatible with the corneal stroma in terms of the complete absence of clinical and histologic inflammation, and attachment of the flap was improved. Since no sutures were used, potential complications related to suturing were avoided, and surgery time was probably shortened.
However, this tissue adhesive is not ideal. It is of human origin and, therefore, despite all U.S. Food and Drug Administration approval precautions, it might harbor viruses. The reconstitutional process is tedious, critical, and time-consuming, and there is rapid, irreversible clotting once it is applied to the surface, with little "working time."
In the control group, the presence of tissue debris in the absence of microscopic gapping in two corneas may have been the result of early postoperative dehiscence. The lamellar adhesion takes place mainly through physical forces, in addition to the chemical bond that occurs in tissues containing collagen. 13 The tensile strength of the bond was tested in dogs whose aorta was incised and subsequently sealed with the adhesive; the results showed that the adhesive could withstand high hemodynamic strain. 13 Although presumably the tensile strength of the bond is not great, it should be adequate to affix tissue that is simply applied to a surface and not subjected to much lateral stress. The adhesive is permeable to metabolites, optically clear, permits healing, and disappears within days or weeks, although the exact duration in the cornea is not known.
The swelling pressure of the cornea is also the pressure that tends to hold the layers together as fluid is pumped out of the stroma and the epithelial and endothelial surfaces resist fluid inflow. The pioneering work of Ytteborg and Dohlman 14 and the subsequent work of Klyce et al., 15 as summarized in The Cornea, 16 indicate that this swelling pressure can be diminished by inflow of fluid from either surface. The restoration of an impermeable epithelial surface favors the restoration of the swelling pressure within the cornea, tending to hold the impermeable surfaces together, and also favors adhesion of the LASIK flap. Although other phenomena may be involved in lamellar flap adhesion, the restoration of stromal dehydration and the swelling pressure that helps to hold the layers together play an important role in this process.
In the case of a lamellar transplant, tissue adhesion is required only until the epithelium resurfaces the graft and re-establishes tight junctions across the surface of the cornea, after which it will adhere like any other microkeratome-cut free cap. Epithelium that is impermeable to aqueous fluids allows the natural swelling pressure and endothelial pump of the cornea to pull the tissue together. Anatomical healing of connective tissue is not required for initial flap adhesion, just as it is not required in LASIK.
A good tissue adhesive has great potential for use in ophthalmic surgery. It could eliminate even the occasional use of sutures after cataract surgery, permit the adhesion of amniotic membrane over corneal ulcers as a simple outpatient procedure done at the slit lamp, attach conjunctival flaps after excision of pterygia, repair lamellar corneal defects, and substitute for sutures in attaching the conjunctiva after surgery. For removal of superficial corneal scars, microkeratome-cut donor tissue affixed to a microkeratome-cut lamellar bed may be superior to phototherapeutic keratectomy in terms of uniformity of scar removal and postsurgical optics. We think that this new tissue adhesive offers significant potential benefits in ophthalmology.
FIG. 2.
Histopathologic specimen from rabbit cornea with flap not bonded with tissue adhesive (control). Gapping (arrowheads) and tissue debris are seen at the interface (arrow) 10 days after surgery. Toluidine blue and basic fuchsin, original magnification ‫.01ן‬ In place, clear Tissue debris in the interface 6
In place, clear Tissue debris in the interface *Rabbit sacrificed on first postoperative day. †Infection.
